Outline
Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
Authors
Abstract
Severe COVID-19 disease is currently being managed with glucocorticoids. As a result, there are increasing reports of COVID-19 associated mucormycosis. (CAM) Patients with diabetes mellitus, organ transplant recipients, and in immune-compromised patients either due to cancer chemotherapy or with HIV and AIDS are at high risk of developing CAM. Pharmacotherapy with antifungal agents like Amphotericin B and surgery are the main treatment options. In this narrative review, we will discuss the challenges and anesthetic concern while managing CAM.
References
- 1.References are in the PDF file of the article.
Copyright
© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the COVID-19 Area: A Consensus of Iranian Experts
Pakdel F, Mardani M, Salehi M, Khodavaisy S, Tabari A, et al. Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the COVID-19 Area: A Consensus of Iranian Experts. Arch Clin Infect Dis. 2022;17(4):e127072. doi: https://doi.org/10.5812/archcid-127072
Mucormycosis Following COVID-19: A Comprehensive Case Series Investigation
Ghazizadeh M, Mohseni M, Asadi M, Hoseini A. Mucormycosis Following COVID-19: A Comprehensive Case Series Investigation. Arch Clin Infect Dis. 2024;19(2):e141644. doi: https://doi.org/10.5812/archcid-141644
Risk Factors for Mucormycosis in COVID-19 Patients
Taghinejad Z, Asgharzadeh M, Asgharzadeh V, Kazemi A. Risk Factors for Mucormycosis in COVID-19 Patients. Jundishapur J Microbiol. 2021;14(8):e117435. doi: https://doi.org/10.5812/jjm.117435
Facial Ulcer: A Harbinger of Post-COVID-19 Mucormycosis, a Case Report
Belgaumkar VA, Chavan RB, Bhatt N, Shriniwas Ambike J. Facial Ulcer: A Harbinger of Post-COVID-19 Mucormycosis, a Case Report. J Skin Stem Cell. 2021;8(1):e117861. doi: https://doi.org/10.5812/jssc.117861
COVID-19 Associated Mucormycosis and Risk Factors: A Case-Control Study from Turkey
Kılınç Toker A, Turunc Ozdemir A, Kanat A, Eryilmaz Eren E, Sav H, et al. COVID-19 Associated Mucormycosis and Risk Factors: A Case-Control Study from Turkey. Jundishapur J Microbiol. 2024;17(4):e146817. doi: https://doi.org/10.5812/jjm-146817
More by these authors
- Scopus by DOI: 1
Last Update: 1 month ago
- Scopus by Title: 1
Last Update: 1 month ago
- Scopus by Title (Ref): 1
Last Update: 1 month ago
- CrossRef: 0
Last Update: 3 days ago